BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3572543)

  • 1. Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis.
    Drane WE; Karvelis K; Johnson DA; Curran JJ; Silverman ED
    J Nucl Med; 1987 May; 28(5):810-5. PubMed ID: 3572543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive systemic sclerosis: radionuclide esophageal scintigraphy and manometry.
    Drane WE; Karvelis K; Johnson DA; Curran JJ; Silverman ED
    Radiology; 1986 Jul; 160(1):73-6. PubMed ID: 3715047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities.
    Johnson DA; Drane WE; Curran J; Benjamin SB; Chobanian SJ; Karvelis K; Cattau EL
    Arch Intern Med; 1987 Sep; 147(9):1597-601. PubMed ID: 3632168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Nutcracker" esophagus: diagnosis with radionuclide esophageal scintigraphy versus manometry.
    Drane WE; Johnson DA; Hagan DP; Cattau EL
    Radiology; 1987 Apr; 163(1):33-7. PubMed ID: 3823454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal scintigraphy to quantitate esophageal transit (quantitation of esophageal transit).
    Tolin RD; Malmud LS; Reilley J; Fisher RS
    Gastroenterology; 1979 Jun; 76(6):1402-8. PubMed ID: 437438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of esophageal and gastric emptying in progressive systemic sclerosis.
    Maddern GJ; Horowitz M; Jamieson GG; Chatterton BE; Collins PJ; Roberts-Thomson P
    Gastroenterology; 1984 Oct; 87(4):922-6. PubMed ID: 6468880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical esophageal motility: evaluation with US in progressive systemic sclerosis.
    Takebayashi S; Matsui K; Ozawa Y; Nozawa T; Fujioka E
    Radiology; 1991 May; 179(2):389-93. PubMed ID: 2014279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radionuclide esophageal transit in progressive systemic sclerosis.
    Carette S; Lacourciere Y; Lavoie S; Hallé P
    J Rheumatol; 1985 Jun; 12(3):478-81. PubMed ID: 4045847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis.
    Akesson A; Gustafson T; Wollheim F; Brismar J
    Scand J Rheumatol; 1987; 16(4):291-9. PubMed ID: 3629208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients of patients with PSS.
    Ramirez-Mata M; Ibañez G; Alarcon-Segovia D
    Arthritis Rheum; 1977; 20(1):30-4. PubMed ID: 319806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal scintigraphy with a semisolid meal to evaluate esophageal dysmotility in systemic sclerosis and Raynaud's phenomenon.
    Bestetti A; Carola F; Conciato L; Marasini B; Tarolo GL
    J Nucl Med; 1999 Jan; 40(1):77-84. PubMed ID: 9935061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metoclopramide effect on esophageal peristalsis in normal human volunteers.
    DiPalma JA; Perucca PJ; Martin DF; Pierson WP; Meyer GW
    Am J Gastroenterol; 1987 Apr; 82(4):307-10. PubMed ID: 3565333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide.
    Horowitz M; Maddox A; Maddern GJ; Wishart J; Collins PJ; Shearman DJ
    Gastroenterology; 1987 Mar; 92(3):570-7. PubMed ID: 3817383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of esophageal function in systemic sclerosis.
    Klein HA; Wald A; Graham TO; Campbell WL; Steen VD
    Gastroenterology; 1992 May; 102(5):1551-6. PubMed ID: 1568564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal function in progressive systemic sclerosis.
    Krejs GJ; Lobsiger MM; Rau R; Bron BA; von Büren US; Peter P; Brändli HH; Pirozynski W; Blum AL
    Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):40-6. PubMed ID: 1258601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclide esophageal emptying and manometric studies in diabetes mellitus.
    Keshavarzian A; Iber FL; Nasrallah S
    Am J Gastroenterol; 1987 Jul; 82(7):625-31. PubMed ID: 3605023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications.
    Sridhar KR; Lange RC; Magyar L; Soykan I; McCallum RW
    J Lab Clin Med; 1998 Dec; 132(6):541-6. PubMed ID: 9851745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Esophageal dysfunction in patients with progressive systemic sclerosis and mixed connective tissue diseases.
    Dantas RO; Villanova MG; de Godoy RA
    Arq Gastroenterol; 1985; 22(3):122-6. PubMed ID: 3836619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of radionuclide liquid bolus transport and esophageal manometry.
    Richter JE; Blackwell JN; Wu WC; Johns DN; Cowan RJ; Castell DO
    J Lab Clin Med; 1987 Feb; 109(2):217-24. PubMed ID: 3805872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Esophageal motility and gastric emptying in PSS patients, correlation with symptoms].
    Satake K; Hongo M; Ujiie H; Okuno Y; Toyota T; Lin YF
    Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1629-35. PubMed ID: 2232296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.